A detailed history of Bell Investment Advisors, Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 34 shares of HAE stock, worth $2,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 33 3.03%
Holding current value
$2,342
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.45 - $91.58 $72 - $91
1 Added 3.03%
34 $2,000
Q2 2024

Aug 07, 2024

BUY
$81.24 - $97.37 $487 - $584
6 Added 22.22%
33 $2,000
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $837 - $1,123
17 Added 170.0%
27 $2,000
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $842 - $1,268
-17 Reduced 62.96%
10 $1,000
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $1,555 - $1,905
27 New
27 $2,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.